Aim: Cinnamon extracts rich in procyanidin oligomers have shown to improve pancreatic β-cell function in diabetic db/db mice. The aim of this study was to identify the active compounds in extracts from two species of cinnamon responsible for the pancreatic β-cell protection in vitro. Methods: Cinnamon extracts were prepared from Cinnamomum tamala (CT-E) and Cinnamomum cassia (CC-E). Six compounds procyanidin B2 (cpd1), (-)-epicatechin (cpd2), cinnamtannin B1 (cpd3), procyanidin C1 (cpd4), parameritannin A1 (cpd5) and cinnamtannin D1 (cpd6) were isolated from the extracts. INS-1 pancreatic β-cells were exposed to palmitic acid (PA) or H 2 O 2 to induce lipotoxicity and oxidative stress. Cell viability and apoptosis as well as ROS levels were assessed. Glucose-stimulated insulin secretion was examined in PA-treated β-cells and murine islets. Results: CT-E, CC-E as well as the compounds, except cpd5, did not cause cytotoxicity in the β-cells up to the maximum dosage using in this experiment. CT-E and CC-E (12.5-50 μg/mL) dose-dependently increased cell viability in both PA-and H 2 O 2 -treated β-cells, and decreased ROS accumulation in H 2 O 2 -treated β-cells. CT-E caused more prominent β-cell protection than CC-E. Furthermore, CT-E (25 and 50 μg/mL) dose-dependently increased glucose-stimulated insulin secretion in PA-treated β-cells and murine islets, but CC-E had little effect. Among the 6 compounds, trimer procyanidins cpd3, cpd4 and cpd6 (12.5-50 μmol/L) dose-dependently increased the cell viability and decreased ROS accumulation in H 2 O 2 -treated β-cells. The trimer procyanidins also increased glucose-stimulated insulin secretion in PA-treated β-cells. Conclusion: Trimer procyanidins in the cinnamon extracts contribute to the pancreatic β-cell protection, thus to the anti-diabetic activity.
Introduction
As a common spice, cinnamon may be a potential treatment for type 2 diabetes. Several clinical studies found that cinnamon supplements decreased the fasting serum glucose, triglyceride, total cholesterol and HbA1c levels in type 2 diabetic patients [1] [2] [3] . Furthermore, cinnamon extracts improved the glucose profiles in animal models. Qin et al found that cinna-# These authors contributed equally to this work. * To whom correspondence should be addressed.
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ymlius@163.com (Yi-ming LI) Received 2016-01-17 Accepted 2016-03-28 mon extract enhanced the insulin sensitivity in normal rats [4] . The blood glucose level in streptozotocin-induced diabetic rats or type 2 diabetic db/db mice was also reduced after cinnamon administration [5] [6] [7] [8] . Although these studies suggest a beneficial effect of cinnamon in treating diabetes, the biological effects of cinnamon in the treatment of type 2 diabetes remain controversial. For example, some studies reported that cinnamon supplementation did not have any significant effects on type 2 diabetic patients [9, 10] . Cinnamon is produced from the bark of multiple species of Cinnamomum, which contains a variety of compounds, such as cinnamaldehyde, eugenol, and polyphenols [11] . Recently, active water-soluble components were isolated and found to Trimer procyanidin oligomers contribute to the protective effects of cinnamon extracts on pancreatic β-cells in vitro 1084 www.nature.com/aps Sun P et al Acta Pharmacologica Sinica mediate beneficial effects on glucose metabolism [12] [13] [14] . These components were identified as polyphenols, also named procyanidins, which usually occur as oligomers of epicatechin and the flavonoid catechin [13] . Our previous studies also confirmed that procyanidin oligomer-rich cinnamon extracts improved the glucose profiles in diabetic animals [7, 8] . In a further study on the hypoglycemic effect of cinnamon extracts on db/db mice, we found that extracts isolated from two species of the genus Cinnamomum, Cinnamomum cassia (C cassia) and Cinnamomum tamala (C tamala), both exerted different antidiabetic pharmacological effects, which improved not only the insulin sensitivity but also the pancreatic β-cell function in db/ db mice [15] . Therefore, we hypothesized that β-cell protection is an important mechanism for the anti-diabetic effect of cinnamon. Furthermore, our other study confirmed that a one trimer procyanidin oligomer isolated from cinnamon extract, cinnamtannin D-1, protected pancreatic β-cells from lipotoxicity [16] . Therefore, to explore the mechanisms involved in the antidiabetic effect of cinnamon, further investigations of β-cell protection using cinnamon extracts or purified procyanidin oligomers are important. The objective of this study was to verify, in vitro, the protective effects of cinnamon extracts from C cassia and C tamala on lipotoxic pancreatic β-cells, as well as the effects of different procyanidin oligomers isolated from these two species of Cinnamomum.
Materials and methods
Plants and sample preparation C cassia and C tamala were collected in 2014 from the Guangxi and Yunnan provinces, respectively. The samples were botanically authenticated by Professor Guan-yun GU at the School of Pharmacy, Fudan University. The voucher specimens, numbers RG012 and RG013, were deposited at the Herbarium of the Department of TCM Chemistry, School of Pharmacy of Shanghai University of Traditional Chinese Medicine (Shanghai, China). The extraction methods for the two cinnamon samples, C cassia and C tamala, and the analysis of these two cinnamon extracts and six compounds isolated from the extracts were described in our previous study [15, 17] . The bioactivity of CC-E (bark extract from C cassia), CT-E (bark extract from C tamala) and six compounds was investigated in this study. The high performance liquid chromatography (HPLC) chromatographic profiles of CC-E and CT-E are provided in the supplementary data, which was described in our previous study [15, 17] . The HPLC fingerprints and structures of the compounds, procyanidin B2 (cpd1), (-)-epicatechin (cpd2), cinnamtannin B1 (cpd3), procyanidin C1 (cpd4), parameritannin A1 (cpd5) and cinnamtannin D1 (cpd6), are shown in Figure  1 . These compounds were analyzed by HPLC using a solvent system with 0.1% acetic acid and acetonitrile, and the purity of the compounds was greater than 95% (Supplementary Table 3 and 4).
Cell culture and isolation of murine islets All reagents used in cell culture were purchased from GIBCO (Carlsbad, CA, USA). The INS-1 rat insulinoma cell line was cultured in Roswell Park Memorial Institute (RPMI)-1640 medium. The MIN6 mouse insulinoma cell line was cultured in Dulbecco's modified Eagle medium (DMEM) containing 25 mmol/L glucose [18] . A concentration of 10% fetal bovine serum (FBS) and 50 μmol/L of β-mercaptoethanol were added to the medium to maintain cell growth. Murine islets were isolated from 8-week old male C57BL6 mice, described in our previous study [16] . All animal experiments were permitted by the IACUC of Shanghai Institute of Materia Medica. All cells were kept at 37 °C and 5% CO 2 in humidified air.
Cell viability assay, Hoechst 33342 staining and reactive oxygen species (ROS) determination Cell viability was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, SigmaAldrich, St Louis, MO, USA) assay as previously described [16] . To detect the cytotoxicity of each compound, different doses of CC-E, CT-E and the six procyanidins were added into the medium and incubated for 48 h separately. To determine the effect of the compounds on cell viability in palmitic acid (PA) or H 2 O 2 treated pancreatic β-cells, INS-1 and MIN6 cells were treated with 0.4 mmol/L PA in the presence of different doses of compounds for 48 h. For the H 2 O 2 model, the cells were pre-incubated with compounds for 4 h and subsequently exposed to 0.5 mmol/L H 2 O 2 with compounds for another 2 h. Then, cell viability was measured using the MTT assay. The value was calculated as the inhibition ratio (% of control group).
Hoechst 33342 staining was performed to observe the effect of CC-E and CT-E on PA-induced apoptosis in INS-1 cells. The cells were incubated with 0.4 mmol/L PA in the presence of different doses of extracts for 48 h. Then, Hoechst 33342 staining was performed as previously described [16] . The apoptotic ratio in each group was calculated as the apoptotic cell number divided by the total cell number.
For ROS determination, the cells were treated with different doses of CC-E, CT-E or procyanidins for 4 h. Then, the ROS level was measured as previously described [16] . The fluorescence of the intracellular ROS was observed using fluorescence microscopy (DP70, Olympus, Tokyo, Japan), and the fluorescence absorption of ROS was also measured using a microplate reader (FlexStation III, Molecular device, Sunnyvale, CA, USA).
Glucose stimulated insulin secretion (GSIS)
The cells/islets were seeded into 24-well plates (100 000 cells or 20 islets per well). Then, the cells/islets were incubated with 0.4 mmol/L PA in the presence/absence of different doses of CC-E or CT-E for 48 h. The GSIS assay was performed as previously described [16] .
Immunofluorescence
The translocation of PDX1 into the nucleus was detected by immunofluorescence. Cultured islets were incubated with 0.4 mmol/L PA in the presence/absence of 25 or 50 μg/mL of CT-E for 48 h. Then, the islets were fixed in 4% paraformaldehyde for 2 h and washed in PBS. After incubation in 0.1% Triton-X100 at 37 °C for 30 min, the islets were incubated with rabbit anti-PDX1 antibody (1:100, Upstate, New York, NY, US) at 4 °C overnight. After multiple washes, AlexaFluor488-conjugated secondary antibody was incubated with the islets for 2 h at room temperature to label the PDX1 with green fluorescence. Cell nuclei were stained with Hoechst 33342 dye.
Statistical analysis
All data are expressed as the mean±SD. One-way ANOVA followed by Dunnett's test was used to calculate differences, and P<0.05 was considered statistically significant.
Results
CC-E and CT-E protected INS-1 β-cells from PA-induced dysfunction and apoptosis As shown in Figure 2A , there was no obvious cytotoxicity of CC-E or CT-E on INS-1 pancreatic β-cells up to 100 μg/mL. However, the PA-induced decrease in cell viability was suppressed by both CC-E and CT-E in a dose-dependent manner (Figure 2A ). Interestingly, CT-E had a better ameliorative effect on PA-induced cells than CC-E. To further determine whether the alteration of cell viability was due to apoptosis, Hoechst 33342 staining was performed to detect the apoptotic ratio in PA treated INS-1 cells in the presence/absence of CC-E or CT-E. The nuclei of the apoptotic cells displayed highly condensed chromatin upon Hoechst 33342 staining compared to normal cells. In PA-treated INS-1 cells, the apoptotic ratio was 6-7-fold greater than the control ( Figure 2B and 2C). However, co-incubation with both CC-E and CT-E dosedependently reduced the PA-induced apoptosis, and CT-E showed better protective effects ( Figure 2B and 2C).
CC-E and CT-E attenuated H 2 O 2 -induced dysfunction and increase in ROS level in INS-1 β-cells The effect of cinnamon extracts on acute H 2 O 2 -induced oxidative stress and apoptosis in INS-1 β-cells was tested. Figure  3A shows that pre-incubation with CC-E and CT-E dosedependently suppressed the H 2 O 2 -induced decrease in cell viability. Additionally, both the intracellular ROS determination and fluorescent staining confirmed that H 2 O 2 -stimulated ROS generation was inhibited by these two cinnamon extracts ( Figure 3B and 3C ).
The protective effect of procyanidin oligomers on INS-1 β-cells
The effect of the six main procyanidin oligomers isolated from CC-E and CT-E on PA-impaired INS-1 cells was investigated. Except for cpd5 (tetramer procyanidin parameritannin A1) at 50 and 100 μmol/L concentrations, there was no cytotoxicity of these compounds on INS-1 cells up to 100 μmol/L ( Figure  4A and 4B). We found that cpd3 and cpd6 dose-dependently protected INS-1 cells from the PA-induced decrease in cell viability ( Figure 4A and 4B) . Furthermore, cpd4, the B-type trimer procyanidin C1, generated weaker protective effect on cells ( Figure 4B ). It was also confirmed that cpd3, cpd4 and cpd6 inhibited the H 2 O 2 -induced decrease in cell viability and H 2 O 2 -stimulated ROS generation in a dose-dependent manner ( Figure 4C and 4D). However, there was a less protective effect of cpd1 or cpd2 on PA-treated INS-1 cells.
CT-E and trimer procyanidins improved insulin secretion in lipotoxic β-cells
We next investigated the effect of CC-E and CT-E on insulin secretion in INS-1 cells and primary cultured murine islets. After incubation with 0.4 mmol/L PA in the presence/absence of different doses of CC-E or CT-E for 48 h, INS-1 cells were subsequently stimulated with 11.1 mmol/L glucose for 1 h, and the secreted insulin was then detected. The insulin secretion in PA-treated INS-1 cells was decreased compared to con- Figure 5A ). Co-treatment with CT-E dose-dependently recovered insulin secretion in PA-treated cells ( Figure  5A ). However, another cinnamon extract, CC-E, affected GSIS in lipotoxic β-cells less ( Figure 5A ). We also tested the effect of procyanidins on insulin secretion in β-cells. The three trimer procyanidins, cpd3, cpd4 and cpd6 25 μmol/L, also improved insulin secretion in lipotoxic β-cells ( Figure 5B ). However, the other procyanidins, cpd1, cpd2 and cpd5, had less effect (Figure 5B) . We further studied the protective effect of CT-E on GSIS in PA-treated murine islets. Similar to the results in INS-1 β-cells, CT-E also protected cultured islets from the PAinduced decrease in GSIS ( Figure 5C ). Chronic treatment with PA also reduced the translocation of PDX1 into the nucleus ( Figure 5D ), thereby inhibiting insulin secretion. During cotreatment with CT-E, PDX1 translocation was partly restored in lipotoxic islets ( Figure 5D ), suggesting a protective effect of CT-E on pancreatic β-cells.
Discussion
Although multiple studies have shown that cinnamon extract improves glucose profiles, the protective effect of cinnamon on pancreatic β-cells has not been well studied. Only Bisht et al proposed that cinnamon extracts could protect pancreatic β-cells and improve insulin secretion, but no direct evidence was provided [19] . To further investigate the detailed mechanism, we studied the effect of the two extracts on pancreatic β-cells using pancreatic β-cell lines and primary cultured islets. PA is the most common saturated fatty acid in animals, and it mediates acute and chronic effects on pancreatic β-cells [20] . Long-term exposure to PA results in increased β-cell dysfunction and apoptosis [21] . By contrast, inhibition of PAinduced β-cell apoptosis using small molecule compounds or natural products may serve as potential therapies for type 2 diabetes [22] . Therefore, the effect of CC-E and CT-E on PAimpaired pancreatic β-cells was investigated using pancreatic β-cell lines and cultured islets. We verified that both CC-E and CT-E protected the rat insulinoma cell line INS-1. Similar results were found in mouse insulinoma cell line MIN6 (Supplementary Figure 2 ) pancreatic β-cell lines from PA-induced apoptosis. Furthermore, CC-E and CT-E both improved insulin secretion in PA-treated INS-1 β-cells and cultured islets. Moreover, although complicated mechanisms were involved in PA-induced β-cell dysfunction, using an H 2 O 2 model, we confirmed that the protective effect of CC-E and CT-E on β-cells was at least partially by reducing ROS-induced injury. Taken together, our in vivo [15] and in vitro studies confirm the beneficial effect of CC-E and CT-E on pancreatic β-cells. However, similar to many other nutraceuticals, the precise biological effects of cinnamon extracts on type 2 diabetes are unclear. Notably, the source or genus of plants used in previous studies was not always clarified. Additionally, the precise identification of their constituents was also unknown. Moreover, combinations using various anti-diabetic drugs with cinnamon also contributed to these controversial results. Therefore, we identified the main oligomeric procyanidins in the extracts of two cinnamon species, C cassia and C tamala. The main procyanidins from CC-E and CT-E were different as follows: CC-E mainly contains procyanidin B2 (cpd1), procyanidin C1 (cpd4), and less (-)-epicatechin (cpd2) and cinnamtannin B1 (cpd3), whereas CT-E mainly contains cinnamtannin B1 (cpd3), cinnamtannin D1 (cpd6) and less parameritannin A1 (cpd5). This may explain why CT-E had better protective effects on pancreatic β-cells than CC-E both in vivo and in vitro because the different procyanidin constituents in these two cinnamon extracts contributed to their diverse pharmacological effects.
In this study, we reported the protective effect of different procyanidin oligomers on pancreatic β-cells for the first time. It was found that cpd3 and cpd6, A-type trimer procyanidin oligomers, protected against PA-induced dysfunction. Reducing ROS production may be a possible mechanism involved in the protective effect of these procyanidins. Although not as effective as cpd3 or cpd6, the B-type trimer procyanidin cpd4 also had a protective effect on β-cells. By contrast, cpd5 was toxic to INS-1 cells, whereas cpd1 and cpd2 had no protective effect on pancreatic β-cells. The trimer procyanidins, cinnamtannin B1 and D1, inhibit cyclooxygenase-2 [23] , whereas cinnamtannin B1 exerts anti-oxidative effects in pancreatic acinar cells [24] . Our recent study also showed that cinnamtannin D1 protects against PA-induced β-cell dysfunction by attenuating oxidative stress and reducing nuclear factor kappa B (NF-κB) activation [16] . Therefore, the trimer procyanidin oligomers are important components of cinnamon that protect β-cells, in which A-type trimers are more effective. Furthermore, cpd3 and cpd6 are the main components in CT-E, whereas CC-E only contained cpd4 and a minor amount of cpd3 [15] . This may be why the protective effect of CT-E was superior to CC-E on pancreatic β-cells both in vitro and in vivo. Given the above, pancreatic β-cell protection contributes to the anti-diabetic bioactivity of cinnamon extracts. Furthermore, trimer procyanidins, particularly A-type procyanidin oligomers, may be the main active components in cinnamon extracts. This study verified the effect of different procyanidin oligomers on lipotoxic pancreatic β-cells for the first time, which provides a better understanding of the pharmacological mechanisms of cinnamon extracts in the treatment of diabetes.
